15-75903980-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_147188.3(FBXO22):c.17G>T(p.Cys6Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000101 in 1,577,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_147188.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO22 | NM_147188.3 | c.17G>T | p.Cys6Phe | missense_variant | 1/7 | ENST00000308275.8 | NP_671717.1 | |
FBXO22 | NM_012170.4 | c.17G>T | p.Cys6Phe | missense_variant | 1/6 | NP_036302.1 | ||
FBXO22 | NR_037623.2 | n.103G>T | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO22 | ENST00000308275.8 | c.17G>T | p.Cys6Phe | missense_variant | 1/7 | 1 | NM_147188.3 | ENSP00000307833.3 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152260Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 4AN: 199650Hom.: 0 AF XY: 0.0000185 AC XY: 2AN XY: 107862
GnomAD4 exome AF: 0.00000491 AC: 7AN: 1424822Hom.: 0 Cov.: 31 AF XY: 0.00000567 AC XY: 4AN XY: 705298
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152378Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 29, 2024 | The c.17G>T (p.C6F) alteration is located in exon 1 (coding exon 1) of the FBXO22 gene. This alteration results from a G to T substitution at nucleotide position 17, causing the cysteine (C) at amino acid position 6 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at